Abstract:Infections by pathogens that contain DNA trigger the production of type-I interferons and inflammatory cytokines through cyclic GMP–AMP synthase, which produces 2′3′-cyclic GMP–AMP (cGAMP) that binds to and activates stimulator of interferon genes (STING; also known as TMEM173, MITA, ERIS and MPYS)<a href="#ref-CR1">1</a>,<a href="#ref-CR2">2</a>,<a href="#ref-CR3">3</a>,<a href="#ref-CR4">4</a>,<a href="#ref-CR5">5</a>,<a href="#ref-CR6">6</a>,<a href="#ref-CR7">7</a>,<a href="/articles/s41586-019-0998-5#ref-CR8">8</a>. STING is an endoplasmic-reticulum membrane protein that contains four transmembrane helices followed by a cytoplasmic ligand-binding and signalling domain<a href="#ref-CR9">9</a>,<a href="#ref-CR10">10</a>,<a href="#ref-CR11">11</a>,<a href="#ref-CR12">12</a>,<a href="/articles/s41586-019-0998-5#ref-CR13">13</a>. The cytoplasmic domain of STING forms a dimer, which undergoes a conformational change upon binding to cGAMP<a href="/articles/s41586-019-0998-5#ref-CR9">9</a>,<a href="/articles/s41586-019-0998-5#ref-CR14">14</a>. However, it remains unclear how this conformational change leads to STING activation. Here we present cryo-electron microscopy structures of full-length STING from human and chicken in the inactive dimeric state (about 80 kDa in size), as well as cGAMP-bound chicken STING in both the dimeric and tetrameric states. The structures show that the transmembrane and cytoplasmic regions interact to form an integrated, domain-swapped dimeric assembly. Closure of the ligand-binding domain, induced by cGAMP, leads to a 180° rotation of the ligand-binding domain relative to the transmembrane domain. This rotation is coupled to a conformational change in a loop on the side of the ligand-binding-domain dimer, which leads to the formation of the STING tetramer and higher-order oligomers through side-by-side packing. This model of STING oligomerization and activation is supported by our structure-based mutational analyses.

Structure of STING Bound to Cyclic Di-Gmp Reveals the Mechanism of Cyclic Dinucleotide Recognition by the Immune System

The Structural Basis for the Sensing and Binding of Cyclic Di-Gmp by STING.

Distinct Dynamical and Conformational Features of Human STING in Response to 2'3'-cGAMP and c-di-GMP.

Detection of Cyclic Dinucleotides by STING.

Progress in innate immunity signaling molecule STING

The Mechanism of Double-Stranded DNA Sensing Through the Cgas-Sting Pathway.

Cryo-EM structures of STING reveal its mechanism of activation by cyclic GMP–AMP

Unraveling the Binding Mode of Cyclic Adenosine–Inosine Monophosphate (cAIMP) to STING through Molecular Dynamics Simulations

Structural Basis of STING Binding with and Phosphorylation by TBK1

A Novel Transcript Isoform of STING That Sequesters Cgamp and Dominantly Inhibits Innate Nucleic Acid Sensing

Activation of STING by targeting a pocket in the transmembrane domain

Cyclic GMP-AMP Synthase is Activated by Double-Stranded DNA-Induced Oligomerization

Structural Flexibility and Conformation Features of Cyclic Dinucleotides in Aqueous Solutions

Design and syntheses of a bimolecular STING agonist based on the covalent STING antagonist

Cgas-Sting: the Novel Mechanism of Cytosolic DNA Sensing Pathways

A Conserved PLPLRT/SD Motif Within the C-terminal Tail of STING Mediates the Recruitment and Activation of TBK1

Molecular Dynamics Simulations Reveal the Modulated Mechanism of STING Conformation

Design, Synthesis and Biological Evaluation of (2′,5′ and 3′5′-Linked) cGAMP Analogs that Activate Stimulator of Interferon Genes (STING)

The molecular mechanism of dsDNA sensing through the cGAS-STING pathway

Ligand Strain and Its Conformational Complexity Is a Major Factor in the Binding of Cyclic Dinucleotides to STING Protein

Exploration of the Binding Mechanism of Cyclic Dinucleotide Analogs to Stimulating Factor Proteins and the Implications for Subsequent Analog Drug Design